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Background: The aim of this study is to assess the impact of the Spanish tobacco control 
legislation on smoking behavior and salivary cotinine concentration among smokers. 
Methods: We used data from a longitudinal study, before (2004-2005) and after (2013-2014) 
the implementation of the two national smoking bans (in 2006 and 2011), in a representative 
sample of adults (≥16 years old) from Barcelona (Spain). We only analyzed a subsample of 
continuing smokers (n=116). We conducted a survey on smoking behavior and obtained saliva 
sample for cotinine analyses. We calculated geometric means (GM).  
Results: The salivary cotinine concentration significantly increased 28.7% (GM from 91.7 ng/ml 
to 117.3 ng/ml, p=0.015) after the implementation of the two Spanish smoke-free bans. 
Nonetheless, no pattern of change was observed in the self-reported number of cigarettes 
smoked daily.  
Conclusions: Our study shows a significant increase in the salivary cotinine concentration 
among adult continuing smokers after both Spanish legislations. This increase could be due to 
differences in smoking topography (increase in the depth of inhalation when smoking) along 
with changes in the type of tobacco smoked (increase in smoking roll your own cigarettes or 
mixed used). Our results suggest the need to extend tobacco control policies, focusing on 
reduction of use of any kind of tobacco product and implementing better treatment policies to 
help smokers stop smoking. 
 





Tobacco is the first single leading cause of preventable death in the world (1), being related to 
more than 25 diseases and being responsible for 30% of all cancers, respiratory diseases and 
cardiovascular diseases (2). In 2015, WHO estimated that about 15% (1.1 billion people) of 
worldwide population smoked (3) and that tobacco use is responsible for about six million 
deaths across the world each year, including about 600,000 deaths from the effects of second-
hand smoke (SHS) (4). In Spain, the latest data reported showed that 28% of men and 19% of 
women were tobacco users in 2014 (5) and that more than 60,000 deaths per year were 
attributable to active smoking (6).   
Consequently, two smoke-free laws have been passed in Spain after the approval of the World 
Health Organization Framework Convention on Tobacco Control (WHO FCTC) (7). On the 1st of 
January, 2006, a smoke-free legislation came into effect (Law 28/2005). The law was a 
compendium of public health measures against smoking and included regulations on publicity, 
sale, supply, and consumption of tobacco products (8). Smoking was banned in all indoor 
workplaces, public places, public transport facilities including enclosed stations, hospitals and 
other health care facilities, schools and universities as well as in retail stores and shopping 
centres. However, hospitality venues were subject to only a partial ban. In bars and 
restaurants smaller than 100 m2, the proprietor could choose between permitting or 
prohibiting smoking. Those larger than 100 m2 were defined as smoke-free, but the law 
allowed the proprietor to provide a physically separated and independently ventilated smoking 
area comprising less than 30% of the total floor area. Moreover, several tax reforms followed 
the implementation of the partial ban (9). This law was a great advance for public health in 
Spain; however, it was not complete in terms of health protection from SHS exposure. The 
scientific evaluation of this law showed the need to promote a total ban (10-12). On the 2nd of 
January, 2011, a new law came into force (Law 42/2010), including several tax reforms and 
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extending the smoke-free regulation to all hospitality venues without exception (9) and to 
some outdoor areas, including hospital premises, educational campuses, and playgrounds. 
However, designated smoking rooms are still permitted in psychiatric services, nursing homes, 
prisons and up to 30% of hotel rooms. 
The principal aim of both Spanish tobacco control legislations was to protect non-smoking 
population from tobacco smoke exposure. Therefore, their scientific evaluation focused on 
their effect on SHS reduction, often neglecting research about the effect on active smokers. In 
this sense, a systematic review (13) has concluded that the implementation of smoke-free 
policies and restrictions in public spaces, workplaces or residences lead to a decrease in 
smoking prevalence and cigarette consumption. Moreover, previous studies (14,15) suggest 
that active smokers could be changing their smoking pattern to consuming cheaper tobacco 
products, such as Roll Your Own (RYO) cigarettes, which are subject of little taxation in Spain 
(16). In addition, RYO are usually not filtered (17) and as a result more nicotine (as well as 
other toxicants) is delivered with smoke. There are few studies that assess the impact of 
smoking legislation among the smoking population using a specific biomarker of tobacco 
smoke absorption such as cotinine, which is the major proximate metabolite of nicotine (18). 
In Spain, a previous study assessed the impact of the first legislation among hospitality workers 
who smoke, using self-reported data and information regarding salivary cotinine (19). Cotinine 
concentration in biological fluids (blood, urine or oral fluid, widely referred to as saliva) (20) 
indicates tobacco exposure over the previous 1-2 days (21) and is strongly correlated with the 
number of cigarettes smoked daily (22). Moreover, the cotinine concentration could vary 
within each stage of change (defined in the methods section), according to the number of 
cigarettes smoked, time to first cigarette of the day, and nicotine dependence (23). 
Therefore, the objective of this study is to assess the impact of the Spanish tobacco control 
legislations (laws 28/2005 and 42/2010) on smoking behavior and salivary cotinine 
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concentration among smokers by using a cohort study of adult smokers in Barcelona (Spain) 
along with biomarker information (salivary cotinine concentration).  
2. METHODS 
This is a longitudinal study (cohort study) from a representative sample of the adult population 
(≥16 years at baseline, ≥25 at follow-up) of the city of Barcelona (Catalonia, Spain). The 
baseline study was carried out during the years 2004-2005 (24,25) (n = 1,245) and the follow-
up took place in 2013-2014, after the implementation of both Spanish tobacco control 
legislations. 
To obtain the baseline sample, a representative random sample by age, sex, and district was 
drawn from the official 2001 population census of Barcelona, a reliable source of population-
based information explained elsewhere (24,25). Briefly, the procedure was as follows: a 
personal letter was sent to eligible participants, and trained interviewers contacted the 
subjects at home and informed them about the study. When the index person was not 
contacted (after several attempts following a strict protocol that included visits on weekends 
and during non-working hours) or refused to participate, we randomly selected a substitute in 
the same sex-, age-, and district-group. We asked participants to answer a face-to-face 
questionnaire and to sign a consent form in order to be contacted in the follow-up. From the 
baseline sample, we excluded 235 subjects: 150 after checking their data in the Insured Central 
Registry of Catalonia (101 died and 49 migrated out of the province of Barcelona) and 85 
subjects who did not give consent to be followed up or were minors (<18 years old) in 2004-
2005 and we did not ask consent to re-contact. The percentage of follow-up in this first stage 
was 81.1%. The follow-up was conducted in 2013-2014. In total, 72.9% of the eligible sample 
agreed to participate (736 out of 1010 traced, second stage of follow-up), 18.5% refused to 
participate, 7.2% had moved elsewhere and 1.4% had died. The final sample included 736 
individuals (Figure 1) and was skewed as slightly older in comparison with the general 
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population of Barcelona. For this reason, we weighted our data according to the age 
distribution of the city of Barcelona to maintain its representativeness. The percentage of 
participation in both stages was 51.9% (736 out 1245). We did not find statistically significant 
differences between the followed-up sample (n=736) and the participants lost in the second 
stage (n=274) according to age, sex, educational level (categorized as low: unschooled, 
elementary school completed or uncompleted and special education; intermediate: high 
school and training cycles; and high: university education) and smoking status. However, we 
described statistically significant differences according to age, level of education and smoking 
status between the follow-up sample (n=736) and the participants lost in both stages of the 
follow-up (n=509) (Table 1). 
We asked the participants to provide a 9 ml sample of saliva for cotinine analysis, using the 
same protocol before and after the Spanish tobacco control legislations. Participants were 
asked to rinse their mouths and then suck a lemon candy (Smint) to stimulate saliva 
production. Saliva samples were frozen and sent to the IMIM-Hospital del Mar Medical 
Research Institute in Barcelona. Saliva samples were analyzed using liquid chromatography-
tandem mass spectrometry (LC/MS/MS) with multiple reaction monitoring. The limit of 
quantification was 0.4 ng/ml (quantification error was <15%) (26).  
We used the same core questionnaire in both surveys to gather relevant information on 
smoking characteristics, along with the information on their cotinine concentration. Smoking 
status, was obtained from the question: “Which of the following statements better describes 
your smoking status?” with the possible answers: ‘Nowadays I smoke everyday (at least one 
cigarette per day)’, these are current daily smokers; ‘Nowadays I smoke occasionally (less than 
one cigarette per day)’, these are current occasionally smokers; ‘I don’t smoke now, but I 
smoked before every day’, these are former daily smokers; ‘I don’t smoke now, but I smoked 
before occasionally’, these are former occasionally smokers; and ‘I have never smoked’, these 
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are never smokers. We also aggregated these categories when appropriate as ‘smokers’ 
(current daily and occasionally smokers) and ‘non-smokers’ (former daily and occasionally 
smokers plus never-smokers). The percentage of self-reported smokers with salivary cotinine 
inconsistent with active smoking (≤ 35 ng/ml per cigarette smoked daily (27)) was 3.4% before 
the legislations and 12.1% after the legislations, accounting for 13.8% of the total sample of 
continuing smokers (n=116). Moreover, when using the self-reported number of cigarettes 
smoked in the last 24 hours and in the last 48 hours, the percentage of inconsistent smokers in 
the total sample of continuing smokers decreased to 6.0% and 0.8% respectively. However, for 
this analysis, we used self-reported smoking status for the identification of current smokers in 
order to maximize the available sample size. The final sample for this analysis consists of 116 
continuing smokers, that is to say, those who self-reported active smoking before and after the 
legislation (Figure 1).  
From the same questionnaire before and after the two laws, we also obtained information 
about the type of tobacco smoked, obtained through the question: “What kind of tobacco 
product do you habitually consume?” with the possible answers: “cigarettes”, “RYO 
cigarettes”, “cigars”, “little cigars”, “pipes”, “hookah” and “e-cigarettes”. The answers to this 
question were dichotomized as ‘CC-CC’ indicating those who only smoked conventional 
cigarettes (CC) before and after the two laws, ‘CC - RYO’, indicating those who switched from 
conventional to RYO cigarettes, ‘CC – MU’, indicating those who switched from conventional to 
mixed use (CC and RYO) and ‘Other’, indicating other possible options. Moreover, we collected 
self-reported information about the smokers’ stage of change (28): precontemplation, when 
smokers were not seriously considering quitting within the next 6 months; contemplation, 
when smokers were seriously considering quitting within the next 6 months but not within the 
next 30 days; and preparation, when smokers were planning to quit within the next 30 days 
and had attempted to quit for at least 24 hours in the past year.  The information to obtain 
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smoker’s stage of change was obtained through two different questions. 1) “Are you seriously 
considering the possibility of…?” with the possible answers: ‘quit smoking during the following 
week’, ‘quit smoking during the following month’, ‘quit smoking during the following three 
months’, quit smoking during the following six months’, ‘quit smoking during the following 
twelve months’, ‘quit smoking but not during the following twelve months’, and ‘no quit 
smoking’. 2) “In the last year, have you been at least one day without smoking?” (not taking 
into account days in which you have been ill), with the possible answers: ‘yes’, ‘no’, and 
‘doesn’t know or doesn’t answer’. We also gathered information about the number of 
cigarettes smoked daily (either conventional or RYO cigarettes) and the Fagerström Test for 
Cigarette Dependence (FTCD) score (28) categorized as ‘low’ (≤4), ‘medium’ (5) and ‘high’ (≥6). 
FTCD score includes six items: time to first cigarette (0 – 3 points), difficulty to refrain (0 – 1 
points), hardest cigarette to give up (0 – 1 points), cigarettes per day (0 – 3 points), smoking 
more in the morning than in the rest of the day (0 – 1 points), and smoking while ill (0 – 1 
points). FTCD score ranges from 0 to 10 and assesses distinguishable self-reportable 
pharmacological dimensions of nicotine addiction (29). Finally, we gathered self-reported 
information about several smoking characteristics, such as use of regular or non-regular 
cigarettes (light, ultralight, etc.), type of tobacco smoked (blond or black), use of cigarettes 
with or without filter, length of cigarettes left after smoking (in centimeters), depth 
(superficial, intermediate, deep) and frequency of inhalation (continuous, regular, scarce).  
For statistical analysis we calculated geometric means (GM) and their geometric standard 
deviation (GSD), given the skewed distribution of cotinine concentration. We used linear mixed 
effect models with individuals as random effects to model the change in cotinine 
concentration (after log10 transformation), their 95% confidence intervals and the p-value, 
adjusted for sex, age, and educational level. The results were stratified by sex, age, educational 
level, kind of tobacco smoked, FTCD score and stages of change. We also used generalized 
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linear mixed models with individuals as random effects to calculate the prevalence ratio of the 
change in smoking characteristics. The statistical programs used were R-3.0.2 and Stata v14. 
 
3. RESULTS 
When analysing self-reported data from the whole sample (n=736), 166 participants (22.6%, 
95% CI: 19.7–25.8) were continuing smokers and 456 participants (62.0%, 95% CI: 58.4–65.5) 
were continuing non-smokers (never and former smokers). In other words, they showed the 
same smoking status at baseline and at follow-up. Moreover, 88 participants (11.9%) quit at 
follow-up and 26 participants (3.5%) initiated or relapsed tobacco use at the follow up (2 
participants, 0.2%, were never smokers at baseline and 24 participants, 3.3%, were former 
smokers). 
According to cotinine levels from the whole sample (n=503 due to missing data), 115 
participants (22.9%, 95% CI: 19.3-26.8) were continuing smokers and 360 participants (71.6%, 
95% CI: 67.4-75.4) were continuing non-smokers (never and former smokers). Moreover, 20 
participants (4.0%) quit at follow-up, 5 participants (1.0%) initiated or relapsed tobacco use at 
the follow up, and 3 participants (0.6%) were not properly classified.  
In addition, when comparing self-reported smoking status with cotinine classification at 
baseline (n=566 due to missing data), 144 out of 207 (69.6%) self-reported smokers were 
correctly classified as such according to cotinine levels, and 100% of self-reported non-smokers 
(359) were also correctly classified. Similarly, when comparing at the follow-up (n=582 due to 
missing data), 107 out of 140 (76.4%) self-reported smokers were correctly classified as such 
according to cotinine levels, and 428 out of 442 (96.8%) of self-reported non-smokers were 
also correctly classified. 
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Among self-reported continuing smokers, we observed a general increase in salivary cotinine 
concentration after the implementation of the two Spanish smoke-free laws (Figure 2, panel 
B). Salivary cotinine concentration significantly increased by 28.7% (GM from 91.1 ng/ml to 
117.3 ng/ml, p=0.015) after the implementation of the two Spanish smoke-free laws (Table 2). 
The increase in the salivary concentration was statistically significant among young people, 
highly educated and among those who switched from conventional to RYO (Table 2). In 
addition, a statistically significant decrease was found in the proportion of individuals classified 
in the medium category of FTCD score (from 23.3% to 9.1%, p=0.017) when comparing pre and 
post legislations (Figure 2, panel A). Nonetheless, no clear pattern of change was observed in 
the number of cigarettes smoked daily (Figure 2, panel C). Even though, a non-significant 
increase in the number of cigarettes smoked daily can be observed among those who switched 
from conventional cigarettes only to mixed use (from 16.6 cigarettes/day to 24.3 
cigarettes/day, p=0.270) when differentiating between type of tobacco smoked (Figure 2, 
panel C). In this regard, 8.3% of smokers switched from conventional to mixed use, 13.0% 
switched from conventional to RYO, and 59.1% smoked only conventional cigarettes before 
and after the two laws.  
Regarding other smoking characteristics (Table 3), we observed an increase in the use of 
regular cigarettes (from 66.6% to 76.3%, p=0.019), in the length of cigarettes left after smoking 
(from 1.13 cm to 2.26 cm, p=0.023) and in the depth of inhalations when smoking at the 
expense of the reduction of intermediate depth of inhalation (deep inhalation from 42.4% to 
57.5%, p=0.001) along with a reduction in low frequency of inhalation (from 28.2% to 10.1%, 
p=0.036) (Table 3). 
4. DISCUSSION  
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Among continuing smokers we found an increase in salivary cotinine concentration of around 
29% after both Spanish tobacco control legislations, particularly among younger and highly 
educated smokers. We also observed a switch in the type of tobacco used, from conventional 
to RYO cigarettes or to mixed use in 21.3% of smokers. In addition, we found a statistically 
significant decrease in the proportion of individuals classified as medium in the FTCD score, 
which represents those individuals with a FTCD score of 5 out of 10, that is to say, medium 
dependence to nicotine.  
The hardening hypothesis (30) suggests that smokers who quit over the time are those who 
are less dependent, and the remaining smokers are more dependent. However, previous 
studies have counteracted this hypothesis (31-33) using self-reported questionnaires to 
measure the tobacco or nicotine dependence. In this sense, we did not find differences in 
salivary cotinine concentration, nor in FTCD scores, among those who quit smoking after 
Spanish tobacco control legislations and those who continue smoking (data not shown). On the 
other hand, we found an increase in salivary cotinine among continuing smokers. In this sense, 
when considering biomarkers as a proxy of tobacco dependence (34), our results could 
indicate that continuing smokers became more dependent after Spanish tobacco control 
legislations. However, our study did not show any significant increase in the FTCD score among 
smokers who continue smoking; this could be due to the fact that FTCD only measures the 
dependence of conventional manufactured cigarettes (29). A previous study showed that the 
FTCD has some limitations, such as low internal consistency, floor effects, and that it does not 
address important aspects of addiction to cigarettes (35). Although there is a positive relation 
between the FTCD score, tobacco consumption and salivary cotinine (34,35), other factors 
might also have an effect on cotinine concentration, such as diet and meals, age, sex, race, 
pregnancy, kidney disease, use of estrogen-containing hormone preparations and other 
medications (36). In our work, the effect of age may play a prominent role given the 
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longitudinal structure of our data, that is to say, given that the cohort has aged by ten years 
between baseline and follow-up. In this sense, a previous review showed that total clearance 
of nicotine lowered by 23% in the elderly (age >65) compared to adults (37). If nicotine is 
cleared at a slower rate, it will lead to a prolonged exposure (i.e. it would take more time to 
remove cotinine from the system), and it could also yield to obtain higher levels of cotinine 
under the same smoking consumption patterns. Therefore, the observed increase in salivary 
cotinine could be related to the aged of our cohort. However, the increase in the older group 
of age at follow-up was only of 11%, which represents 13 individuals out of the 116 continuing 
smokers. Our models were adjusted by sex, age and educational level, obtaining similar results 
in the adjusted and unadjusted models. Moreover, smoking topography (24) could also affect 
cotinine concentration.  
According to our results, an increase in smoking regular cigarettes, in the centimeters left 
without smoking and in the depth of inhalation when smoking, along with a reduction in low 
frequency of inhalation, can be observed after the application of the Spanish tobacco laws. 
This could be explained because, under these smoking restriction policies, smokers have fewer 
opportunities to smoke in public places and less time to do so. Thus, changes in the smoking 
topography may be evident. In addition, the low increase in salivary cotinine found in our 
study in high dependent smokers at baseline could be due to a ceiling effect, since the highest 
value of salivary cotinine before bans was observed in this group. Furthermore, it is important 
to bear in mind that the information about FTCD score and the number of cigarettes smoked 
daily was self-reported, therefore it can be subject to potential limitations related to survey 
based studies. Further research is needed to analyze possible factors related to cotinine 




The increase in the salivary concentration was statistically significant among young people, 
highly educated, and among those who switched from conventional cigarettes to RYO. These 
results are likely to be related, since previous works (38) showed a great increase in the 
consumption of hand-rolled tobacco and other tobacco products, especially among young 
people; in fact, according to those results, older people did not smoke hand-rolled tobacco, 
neither before nor after the implementation of the Spanish smoke-free legislations. Moreover, 
we found a significant association between age and education, age and type of tobacco 
smoked, and education and type of tobacco smoked (data not shown). Therefore, the increase 
in the salivary concentration among high-educated individuals might be confounded by age. 
Additionally, our study showed a switch from conventional to RYO cigarettes or to mixed use in 
21.3% of continuing smokers, after both Spanish tobacco control legislations. Thereby, our 
results could be backing the hypothesis of a switch of smokers to cheaper tobacco products, 
such as RYO cigarettes (14,15), because the tobacco control policies, particularly increasing of 
prices, are traditionally focused on conventional cigarettes. Regarding Spain, in recent years, 
the prices of these products have been surprisingly different, with RYO costing remarkably less 
than manufactured cigarettes. Moreover, the economic crisis that took place in Spain in 2008 
could have affected the shift on tobacco products as has been also reported (10). Bearing this 
in mind, there is a need to equalize the prices of all tobacco products by applying the same 
taxing level as, indeed, recommended by the article 6 of the FCTC (39). Furthermore, the 
highest value of salivary cotinine after Spanish smoking bans, according to the kind of tobacco 
smoked, was observed in smokers who switched from conventional to RYO cigarettes or to 
mixed use, and may counteract the popular belief that RYO cigarettes are less harmful than 
conventional cigarettes (40). This aspect may also be involved in the observed increase in 
salivary cotinine after the implementation of Spanish smoking bans. Given that many smokers 
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switched from conventional cigarettes to other tobacco products, there is a need to 
implement new instruments to measure dependence not limited to a specific tobacco product.  
Finally, 68% of continuing smokers were on the preparation stage, indicating that they were 
planning to quit within the next 30 days and that had attempted to quit for at least 24 hours in 
the past year; also 45.7% were classified as having low (FTCD score ≤4) nicotine dependence. 
However, according to the Tobacco Control Scale report of 2013 (36,37), the Spanish score for 
policies related to treatment to help smokers quit was low (6 out of 10 points) in comparison 
with other policies. This could mean that smokers may not receive the help needed to succeed 
when trying to stop smoking or that they are not properly identified. Therefore, there is a need 
to implement better treatment policies to help smokers stop smoking.  
The main limitation of our study is the potential participation bias due to the attrition of the 
cohort of participants. In this sense, there were statistically significant differences according to 
age, level of education, and smoking status between the follow-up sample and the participants 
lost in the follow-up (41). The followed-up sample overestimated young people and smokers in 
comparison with lost participants. For this reason, the increase in salivary cotinine could be 
smaller among lost participants. On the other hand, our sample, being a cohort, overestimated 
the older people compared with the distribution of population in Barcelona. However, we 
weighted the sample to minimize these limitations and to generate estimations representative 
of the general population. Moreover, the baseline sample size was representative of the city of 
Barcelona (24,25) and the longitudinal design maximizes the internal validity of the study. 
Other potential limitations are those related to potential information biases derived from the 
use of a self-reported questionnaire to collect information, and non-response. However, 
trained interviewers administered a face-to-face questionnaire and used the same definition of 
smoking status in both studies, potentially increasing the internal validity of our results. In 
addition, we used salivary cotinine, a specific biomarker of nicotine.  
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In conclusion, this study shows a significant increase in salivary cotinine concentration among 
adult continuing smokers after the implementation of both Spanish legislations. Moreover, we 
observed a shift in the type of tobacco product used, particularly from conventional cigarettes 
to RYO. Our results, therefore, suggest the need to extend tobacco control policies, focusing 
on reduction of use of any kind of tobacco product (i.e. equalizing the prices of all tobacco 
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                                                                                                                       85 did not give consent in 2004-05 to be followed               
 
Information obtained from the Insured Central         
Registry of Catalonia at the beginning of 2013: 
  101 died  
                                                                                   49 migrated out of the province of Barcelona  
                                                                                      
 
 
                                                
     
                                                                                                                       187 refused to participate 
                                                       73 moved away 




                                                                                                                          30 without saliva sample 
590 self-declared being non-smokers or former 
smokers (pre or post) 







Pre: before Spanish smoke-free bans (2004-2005). 





Sample in 2004-2005 
(n=1,245)  
Target subjects to be 
followed up 
(n=1,010) 






Table 1: Differences between follow-up sample and lost in both stages of the follow-up 









Sex                                                              
men 42.2% 45.7% 0.257
a 
women 57.8% 54.3%  
Age (years) 58 (39) 49 (26.25) <0.001
b 
Age    
<45 35.2% 43.9% <0.001
a 
45-64 22% 37.5%  
>=65 42.8% 18.65  
Educational level 
   
               Low 53% 38.9% <0.001a 
               Intermediate 20.5% 24.2% 
 
               High 26.5% 36.9% 
 
Smoking status (follow-up)    
smoker 24.1% 31.1% 0.009
a 
no smoker 75.9% 68.9%  
a. Chi-square test  












Figure 2. Changes in salivary cotinine concentration (log scale), in the number of cigarettes 
smoked daily (log scale), and in the Fagerström Test for Cigarette Dependence (before and 










FTCD categorized as ‘low’ (≤4), ‘medium’ (5) and ‘high’ (≥6) 
Statistically significant differences were only found in the ‘medium’ group when comparing FTCD categories pre and 
post legislation (proportion test).   
Pre: before Spanish smoke-free bans (2004-2005). 
Post: after Spanish smoke-free bans (2013-2014). 
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Table 2. Geometric mean (GM) and geometric standard deviation (GSD), adjusted linear mixed 
effect coefficient (% change*) and their 95% confidence interval (95%CIs) of salivary cotinine 
concentration (ng/mL) according to sociodemographic variables, kind of tobacco smoked, 
Fagerström Test for Cigarette Dependence score (FTCD) and stages of change before (2004-
2005) and after (2013-2014) the implementation of both Spanish tobacco control legislations. 
 
n
a GM (GSD)  
ng/mL (PRE) 
GM (GSD)  
ng/mL (POST) 
% change* (95% CI) p-value 
Overall 116 91.1 (0.16) 117.3 (0.18) 28.7 (4.9; 58.0) 0.015 
Sex 
   
  
               Men 62 103.9 (0.26) 135.2 (0.28) 30.1 (-0.1; 69.4) 0.051 
               Women 54 78.3 (0.19) 99.6 (0.22) 27.2 (-7.8; 75.6) 0.143 
Age 
   
  
               26-44 62 104.3 (0.15) 174.3 (0.09) 67.2 (30.7; 113.8) <0.001 
               45-64 34 132.7 (0.18) 112.9 (0.28) -14.9 (-46.5; 35.2) 0.494 
               65-98 20 30.7 (0.22) 35.3 (0.34) 15.0 (-13.5; 52.9) 0.336 
Educational level 
   
  
               Low 46 102.1 (0.32) 112.5 (0.35) 10.2 (-11.8; 37.7) 0.392 
               Intermediate 33 100.9 (0.22) 142.2 (0.27) 40.9 (-21.1; 151.6) 0.246 
               High 37 72.4 (0.16) 104.0 (0.24) 43.8 (13.9; 81.4) 0.002 
Kind of tobacco smoked
1 
     
               CC - CC  64 106.6 (0.18) 114.9 (0.20) 7.8 (-18.0; 41.9) 0.590 
               CC – RYO 14 145.6 (0.16) 243.2 (0.12) 70.0 (16.7; 138.8) 0.005 
               CC – MU 9 205.2 (0.16) 236.9 (0.14) 15.5 (-12.1; 51.6) 0.301 
               Other 21 74.3 (0.55) 80.8 (0.63) 8.8 (-15.2; 39.5) 0.509 
FTCDd score (PRE)    
  
               Low 53 115.7 (0.12) 137.4 (0.18) 18.7 (-15.3; 66.3) 0.319 
               Medium 20 86.6 (0.43) 103.3 (0.39) 19.3 (-0.9; 43.5) 0.062 
               High 14 237.6 (0.15) 272.3 (0.12) 14.6 (-12.8; 50.7) 0.329 
Stages of Change (PRE) 
   
  
               Precontemplation 6 186.7 (0.36) 257.1 (0.20) 37.7 (-26.0; 156.3) 0.313 
               Contemplation 9 136.8 (0.30) 172.5 (0.25) 26.1 (-11.5; 79.8) 0.200 
               Preparation 79 93.5 (0.21) 115.1 (0.23) 23.1 (-7.3; 63.6) 0.151 
FTCDd: FTCD daily smokers. 
na: The sum does not up the total for some variables because of some missing      values. 
Pre: Before Spanish smoke-free bans (2004-2005). 
Post: After Spanish smoke-free bans (2013-2014). 
% change*: Adjusted by sex, age, educational level. 
P-value: Obtained through adjusted linear mixed effect coefficient. 
1‘CC-CC’ only smoked conventional cigarettes before and after the two laws, ‘CC - RYO’ 
switched from conventional to RYO cigarettes, ‘CC – MU’ switched from conventional to mixed 





Table 3. Prevalence and generalized linear mixed effect coefficient (Prevalence Ratio PR), or 
mean (standard deviation) and mean difference, smoking characteristics before (2004-2005) 




 PRE POST PR  (95% CI) p-value 
Type of cigarettes (%) 
     
              Regular 66 66.6 76.3 1.15 (1.02, 1.28) 0.019
1 
               Other 33 33.4 23.7 0.71 (0.50, 0.99) 0.049
1 
Type of tobacco (%) 
     
               Blond 82 82.2 88.1 1.07 (0.99, 1.16) 0.097
1 
               Black 18 17.8 11.9 0.67 (0.42, 1.06) 0.086
1 
Filter (%) 
     
               Yes 97 98 98 1.00 (0.98, 1.02) 0.96
1 
               No 2 2 2 1.04 (0.35, 3.07) 0.94
1 
Length of cigarettes left after 
smoking in cm (mean, SD) 
107 1.13 (0.12) 2.26 (0.39) -  0.023
2 
Frequency of inhalation (%) 
     
               Continuous 13 11.7 16.9 1.44 (0.83, 2.52) 0.198
1 
               Regular 65 60.1 73 1.21 (0.86, 1.71) 0.264
1 
               Scarce 30 28.2 10.1 0.36 (0.14, 0.93) 0.036
1 
Depth of inhalation (%) 
     
               Superficial 17 16.2 24.7 1.56 (0.73, 3.32) 0.246
1 
               Intermediate 45 41.4 17.8 0.43 (0.26, 0.72) 0.001
1 
               Deep 46 42.4 57.5 1.35 (1.13, 1.61) 0.001
1 
na: The sum does not up the total for some variables because of some missing 
values. 
Pre: Before Spanish smoke-free ban of 2004-2005. 
Post: After Spanish smoke-free ban of 2013-2014. 
PR: Prevalence ratio obtained through generalized linear mixed effect 
coefficient.  
1Generalized linear mixed effect coefficient p-value.  
2T-test for paired samples.  
